The123I-FP-CIT dopamine transporter SPECT imaging is a sensitive method to assess functional dopaminergic neuron terminals in the striatum. The method has also been available in Hungary for years. There are two main indications: (i) to help differentiate essential tremor from clinically uncertain Parkinsonism, including patients with early symptoms and (ii) to help differentiate dementia with Lewy bodies from Alzheimer's disease. The aim of this paper is to review123I-FP-CIT SPECT imaging based on international data/guidelines and our own experiences, thereby assisting nuclear medicine practitioners and neurologists.
|Translated title of the contribution||The applicability of123I-FP-CIT SPECT dopamine transporter imaging in clinical practice|
|Number of pages||8|
|Publication status||Published - Nov 30 2019|
ASJC Scopus subject areas
- Clinical Neurology